Statistics

Total Visits

Views
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment13

Select a period of time:

Number of views in the range

Views
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment8

Views

Views
November 20230
December 20231
January 20241
February 20241
March 20241
April 20241
May 20243
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
 

Top cities views

Views
Chicago3
Boardman2
Ashburn1
Fort Worth1